This topic contains a solution. Click here to go to the answer

Author Question: In latent inhibition, an unfamiliar stimulus is more readily conditioned as a _____ than a familiar ... (Read 85 times)

@Brianna17

  • Hero Member
  • *****
  • Posts: 550
In latent inhibition, an unfamiliar stimulus is more readily conditioned as a _____ than a familiar stimulus.
 
  A) US
  B) CS
  C) NS1
  D) NS2

Question 2

According to Lubow and Gewirtz, a person suffering from schizophrenia is likely to exhibit difficulties with _____.
 
  A) latent inhibition
  B) classical conditioning
  C) aversive conditioning
  D) occasion setting



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcni194

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

B

Answer to Question 2

A




@Brianna17

  • Member
  • Posts: 550
Reply 2 on: Jun 21, 2018
Thanks for the timely response, appreciate it


Laurenleakan

  • Member
  • Posts: 309
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library